Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

KalVista Pharmaceuticals (KALV) Operating Margin (2016 - 2025)

KalVista Pharmaceuticals' Operating Margin history spans 7 years, with the latest figure at 234.23% for Q2 2020.

  • On a quarterly basis, Operating Margin rose 15059.0% to 234.23% in Q2 2020 year-over-year; TTM through Jul 2024 was 1668.99%, a N/A change, with the full-year FY2025 number at 1709.05%, down 142816.0% from a year prior.
  • Operating Margin hit 234.23% in Q2 2020 for KalVista Pharmaceuticals, up from 806.85% in the prior quarter.
  • Over the last five years, Operating Margin for KALV hit a ceiling of 61.34% in Q2 2018 and a floor of 93257.14% in Q1 2016.
  • Historically, Operating Margin has averaged 6612.27% across 5 years, with a median of 384.83% in 2019.
  • Biggest five-year swings in Operating Margin: tumbled -2324286bps in 2016 and later skyrocketed 549169bps in 2018.
  • Tracing KALV's Operating Margin over 5 years: stood at 2043.15% in 2016, then skyrocketed by 74bps to 526.8% in 2017, then skyrocketed by 83bps to 87.5% in 2018, then tumbled by -171bps to 236.96% in 2019, then grew by 1bps to 234.23% in 2020.
  • Business Quant data shows Operating Margin for KALV at 234.23% in Q2 2020, 806.85% in Q1 2020, and 236.96% in Q4 2019.